TMCnet News
Tanner Pharma Group Names Richard Lambie Global Head of Tanner-CTSTanner Pharma Group is pleased to announce the hiring of Richard Lambie as Director and Global Head of TannerCTS, effective September 1, 2015. In this role, Mr. Lambie will oversee the Clinical Trial Sourcing (CTS (News - Alert)) division and lead strategy, business development, sourcing and fulfilment with the aim of achieving market leadership and recognition as "best in class" from partners and customers. He will operate out of Tanner Pharma Group's newly established UK office to ensure close contact with customers and suppliers. Mr. Lambie brings nearly 10 years of experience in the Pharmaceutical Industry; including GCSG EU committee membership, strategic consulting work for Big Pharma and Biotech with a strong focus on the Oncology, the Biologic and the Orphan drug space. This lends him as an asset for both Tanner Pharma Group and clients desiring extra value and partnership with their CTS provider. Prior to joining Tanner Pharma Group, Mr. Lambie worked in various operations within Big Pharma, Specialty Pharma, and most recently consultancy within the pharmaceutical industry. Within these organizations, he worked in various capacities including clinical, marketing, sales, strategy, procurement, quality, and supply chain roles, within K, EU, MENA, and Globally. Mr. Lambie is also a registered Pharmacist and holds an MBA from Imperial College Business School. "Richard's dynamic background in the pharma industry, his in-depth knowledge of clinical trial sourcing, and years of experience in consulting, operations, pharmaceuticals, and business development make him an ideal Global Head for TannerCTS," stated Banks Bourne, Founder of Chairman of Tanner Pharma Group and CEO of Bourne Partners, the parent company of Tanner Pharma Group. The recently established TannerCTS division will help build strong partnerships with Pharmaceutical companies by focusing on collaboration and strategic support. This will enable expansion of our current partnerships combined with the ability to supply the same quality, service, and support to new clients wanting to utilize the unique TannerCTS capabilities. About Tanner Pharma Group For over 15 years, Tanner Pharma Group has provided highly specialized pharmaceutical services to its partners around the world. Leading pharmaceutical and biotech companies partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes, and source comparator drugs for clinical trials and bioanalysis. By partnering with Tanner Pharma, manufacturers are able to focus on their primary markets and strategies while ensuring that the services they need will follow a strictly controlled protocol of quality. Headquartered in Charlotte, N.C., USA, with offices in London, São Paulo and Mexico City, Tanner Pharma Group's reach extends to Europe, Asia, the Middle East, Australia, Canada and Latin America. For more information about Tanner Pharma Group, please visit TannerPharma.com. View source version on businesswire.com: http://www.businesswire.com/news/home/20150903005671/en/ |
